Tenet Healthcare (NYSE:THC) had its price target hoisted by Mizuho from $30.00 to $33.00 in a research note issued to investors on Wednesday, The Fly reports.

Several other research firms have also issued reports on THC. ValuEngine lowered Tenet Healthcare from a sell rating to a strong sell rating in a report on Tuesday. Robert W. Baird increased their target price on Tenet Healthcare from $27.00 to $30.00 and gave the stock a neutral rating in a report on Tuesday. Credit Suisse Group raised Tenet Healthcare from a neutral rating to an outperform rating and raised their price objective for the company from $25.00 to $36.00 in a research note on Wednesday. SunTrust Banks raised their price objective on Tenet Healthcare from $24.00 to $31.00 and gave the company a hold rating in a research note on Wednesday. Finally, Royal Bank of Canada reaffirmed a hold rating and issued a $26.00 price objective on shares of Tenet Healthcare in a research note on Sunday, August 11th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and four have issued a buy rating to the stock. The company presently has a consensus rating of Hold and a consensus price target of $29.64.

THC opened at $29.70 on Wednesday. The firm has a market cap of $2.91 billion, a P/E ratio of 15.97, a price-to-earnings-growth ratio of 0.74 and a beta of 1.66. Tenet Healthcare has a 52-week low of $16.60 and a 52-week high of $31.64. The company has a debt-to-equity ratio of 30.38, a quick ratio of 1.06 and a current ratio of 1.22. The business’s fifty day moving average is $23.99 and its 200-day moving average is $21.88.

Tenet Healthcare (NYSE:THC) last released its earnings results on Monday, November 4th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.30. The company had revenue of $4.57 billion for the quarter, compared to analyst estimates of $4.46 billion. Tenet Healthcare had a positive return on equity of 35.68% and a negative net margin of 1.31%. Tenet Healthcare’s quarterly revenue was up 1.8% on a year-over-year basis. During the same period in the prior year, the firm posted $0.29 EPS. On average, research analysts predict that Tenet Healthcare will post 2.55 earnings per share for the current fiscal year.

In other news, major shareholder Glenview Capital Management, L bought 613,781 shares of the company’s stock in a transaction on Thursday, August 15th. The stock was purchased at an average cost of $20.12 per share, for a total transaction of $12,349,273.72. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Edward A. Kangas sold 45,000 shares of the stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $20.28, for a total value of $912,600.00. Following the completion of the transaction, the director now owns 47,138 shares of the company’s stock, valued at $955,958.64. The disclosure for this sale can be found here. Insiders purchased 1,098,419 shares of company stock worth $22,395,899 over the last ninety days. 1.50% of the stock is currently owned by insiders.

Institutional investors have recently bought and sold shares of the business. Rehmann Capital Advisory Group raised its position in Tenet Healthcare by 62.4% in the second quarter. Rehmann Capital Advisory Group now owns 1,601 shares of the company’s stock valued at $33,000 after purchasing an additional 615 shares during the last quarter. Quadrant Capital Group LLC raised its position in Tenet Healthcare by 152.6% in the third quarter. Quadrant Capital Group LLC now owns 1,546 shares of the company’s stock valued at $33,000 after purchasing an additional 934 shares during the last quarter. KBC Group NV bought a new position in Tenet Healthcare in the second quarter valued at about $53,000. LS Investment Advisors LLC raised its position in Tenet Healthcare by 52.7% in the third quarter. LS Investment Advisors LLC now owns 2,552 shares of the company’s stock valued at $56,000 after purchasing an additional 881 shares during the last quarter. Finally, Financial Architects Inc raised its position in Tenet Healthcare by 41.6% in the third quarter. Financial Architects Inc now owns 2,775 shares of the company’s stock valued at $61,000 after purchasing an additional 815 shares during the last quarter. Hedge funds and other institutional investors own 99.16% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

See Also: Current Ratio

The Fly

Analyst Recommendations for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.